Back
Forte Biosciences Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
39
FBRX
Forte Biosciences
Last Price:
$8.33
Seasonality Move:
-14.46%
Buy
53
ALNY
Alnylam Pharmaceuticals
Last Price:
$269.17
Seasonality Move:
3.3%
Sell
39
Forte Biosciences (FBRX)
is a Sell
Is Forte Biosciences a Buy, Sell or Hold?
-
The current Forte Biosciences [FBRX] share price is $8.51. The Score for FBRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
FBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $280.96. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FBRX Stock Price Chart
What is Forte Biosciences's stock price today?
-
The Forte Biosciences share price today is $8.51The current trend is relatively stagnant and FBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $280.96The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
FBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.21 | Sell |
Relative Strength Index (14 RSI): | 51.04 | Buy |
Chaikin Money Flow: | 116500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.03 - 9.87) | Buy |
Bollinger Bands (100): | (6.64 - 20.06) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.18 | Buy |
Relative Strength Index (14 RSI): | 64.02 | Buy |
Chaikin Money Flow: | -956276 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (237.98 - 264.74) | Buy |
Bollinger Bands (100): | (240.44 - 271.42) | Buy |
FBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.8 | Buy |
20-day SMA: | 7.2 | Buy |
50-day SMA: | 11.34 | Sell |
200-day SMA: | 11.61 | Sell |
8-day EMA: | 7.19 | Buy |
20-day EMA: | 7.79 | Buy |
50-day EMA: | 10.42 | Sell |
200-day EMA: | 12.77 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 262.64 | Buy |
20-day SMA: | 251.27 | Buy |
50-day SMA: | 258.44 | Buy |
200-day SMA: | 252.16 | Buy |
8-day EMA: | 267.69 | Buy |
20-day EMA: | 258.45 | Buy |
50-day EMA: | 256.39 | Buy |
200-day EMA: | 243.81 | Buy |
Forte Biosciences Earnings Growth & FBRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $6.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.36 per share, and an increase next year of $0.99 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Forte Biosciences Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |